Nasdaq-Listed Canton Strategic Completes Sale of Gravitas Life Sciences on July 17

CC-0.16%
According to Odaily, Nasdaq-listed Canton Strategic Holdings completed the sale of its biotech subsidiary Gravitas Life Sciences to Gravitas Collective Corp on July 17, 2026. The transaction was approved unanimously by the company's board. Following the divestment, Canton Strategic will pivot to focus on its Canton Network ecosystem and position itself as a financial market digitalization service provider, prioritizing asset tokenization and regulatory-compliant infrastructure.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments